Ontology highlight
ABSTRACT: Objective
Extremely low gestational age newborns (ELGANs) represent an especially vulnerable population. Herein, we aimed to determine incidence and severity of pulmonary hypertension associated with bronchopulmonary dysplasia (BPD-PH) in extremely immature ELGANs (gestational age: 230/6-256/7 weeks).Methods
In this prospective observational cohort study, we assessed BPD-PH by means of several echocardiography markers and serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels at 3 and 12 months of chronological age. In addition, we analyzed incidence and efficacy of pharmacologic treatment for BPD-PH.Results
At 3 months 15/34 ELGANs had echocardiographic evidence of BPD-PH, while at 12 months of age 6/34 still had PH. PH-targeted therapy consisted of sildenafil monotherapy in 11 and dual oral combination therapy (sildenafil and macitentan) in four ELGANs at 3 and 12 months.Conclusion
44% (15/34) of ELGANs developed BPD-PH. All received PH-targeted pharmacotherapy at 3 months, leading to hemodynamic improvements at 12 months in most infants.
SUBMITTER: Sallmon H
PROVIDER: S-EPMC9184271 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
Sallmon Hannes H Koestenberger Martin M Avian Alexander A Reiterer Friedrich F Schwaberger Bernhard B Meinel Katharina K Cvirn Gerhard G Kurath-Koller Stefan S Gamillscheg Andreas A Hansmann Georg G
Journal of perinatology : official journal of the California Perinatal Association 20220401 6
<h4>Objective</h4>Extremely low gestational age newborns (ELGANs) represent an especially vulnerable population. Herein, we aimed to determine incidence and severity of pulmonary hypertension associated with bronchopulmonary dysplasia (BPD-PH) in extremely immature ELGANs (gestational age: 23<sup>0/6</sup>-25<sup>6/7</sup> weeks).<h4>Methods</h4>In this prospective observational cohort study, we assessed BPD-PH by means of several echocardiography markers and serum N-terminal pro-B-type natriure ...[more]